Cargando…

Pharmacokinetic and Safety Profiles of a Fixed‐Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3‐Period Replicate Crossover Study

The objective of study was to compare the pharmacokinetic and safety profiles of a fixed‐dose combination (FDC) formulation of 5/160/20 mg amlodipine/valsartan/atorvastatin with those of separate formulations of a 5/160‐mg amlodipine/valsartan tablet and a 20‐mg atorvastatin tablet. This was a rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seokuee, Ko, Jae‐Wook, Kim, Jung‐Ryul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187173/ https://www.ncbi.nlm.nih.gov/pubmed/31373174 http://dx.doi.org/10.1002/cpdd.727

Ejemplares similares

No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2018)

Amlodipine and valsartan as components of a rational and effective fixed-dose combination
por: Waeber, Bernard, et al.
Publicado: (2009)

Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects
por: Hwang, Sejung, et al.
Publicado: (2021)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
por: Ghim, Jong-Lyul, et al.
Publicado: (2019)

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study
por: Choi, YoonJung, et al.
Publicado: (2016)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
por: Yoon, Deok Yong, et al.
Publicado: (2020)

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
por: Lee, Soo-Yun, et al.
Publicado: (2015)

Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial
por: Wang, Kang-Ling, et al.
Publicado: (2020)

Simultaneous Determination of Amlodipine and Valsartan
por: Mohamed, Nashwah Gadallah
Publicado: (2011)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update
por: Destro, Maurizio, et al.
Publicado: (2010)

Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure
por: Doménech, Monica, et al.
Publicado: (2010)

Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers
por: Kim, Seokuee, et al.
Publicado: (2018)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects
por: Yang, Eunsol, et al.
Publicado: (2019)

Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
por: Oh, Minkyung, et al.
Publicado: (2018)

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy
por: Ahn, Youngkeun, et al.
Publicado: (2018)

Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
por: Oh, Jin Kyung, et al.
Publicado: (2020)

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
por: Jung, Jin Ah, et al.
Publicado: (2015)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
por: Oh, Minkyung, et al.
Publicado: (2017)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
por: Oh, Minkyung, et al.
Publicado: (2019)

Pharmacokinetics and safety of highly variable valsartan in single-pill combination with amlodipine versus its generic formulation: a randomized, three-cycle, three-sequence, partially replicated crossover phase I bioequivalence clinical trial
por: Qiu, Bo, et al.
Publicado: (2023)

Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension
por: Aabed, Wafa' J., et al.
Publicado: (2021)

The Concomitant Use of Atorvastatin and Amlodipine Leading to Rhabdomyolysis
por: Khan, Salman, et al.
Publicado: (2018)

Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC–ESI-MS/MS and its application to pharmacokinetics in rats
por: Gadepalli, Shankar Ganesh, et al.
Publicado: (2014)

Pharmacokinetic Drug Interaction Between Amlodipine and Tadalafil: An Open-Label, Randomized, Multiple-Dose Crossover Study in Healthy Male Volunteers
por: Kim, Hyungsub, et al.
Publicado: (2022)

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2014)

Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2015)

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
por: Fogari, Roberto, et al.
Publicado: (2010)

Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy
por: Sultan, El-Zahraa M., et al.
Publicado: (2022)

Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension
por: Wang, Xiao-ou, et al.
Publicado: (2019)

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
por: Laffer, Cheryl L, et al.
Publicado: (2011)

Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination
por: Aslam, Farhan, et al.
Publicado: (2009)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
por: Kim, Sung H, et al.
Publicado: (2011)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
por: Jung, Hae Won, et al.
Publicado: (2023)

Pharmacokinetics of atorvastatin and sustained-release metformin fixed-dose combination tablets: two randomized, open-label, 2-way crossover studies in healthy male subjects under fed conditions
por: Choi, Young-Kyung, et al.
Publicado: (2017)

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine
por: Motozato, Kota, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_shj5g1e4cngpecmeg9fjf66g3o